Literature DB >> 12239616

Establishment of human tumoral ependymal cell lines and coculture with tubular-like human endothelial cells.

C Brisson1, I Lelong-Rebel, C Mottolèse, A Jouvet, M Fèvre-Montange, G Saint Pierre, G Rebel, M F Belin.   

Abstract

Ependymomas, rare neoplasms of the central nervous system, occur predominantly in children. They are highly vascularized, and histological findings show many perivascular rosettes of tumoral cells radially organized around capillaries. Treatment of ependymomas relies on surgery combined with radio- or chemotherapy, but the efficiency of chemotherapy is limited, probably because of their multidrug resistance (MDR) phenotype. Progress in the therapy of these neoplasms is dramatically limited by the absence of cell line models. We established conditions for the long-term culture of human tumoral ependymocytes and their 3D coculture in Matrigel with endothelial cells. Histological, immunological, and ultrastructural studies showed that the morphological features (microvilli, cilia, and caveolae) of these cultured cells were similar to those of the tumor in vivo. The cells expressed potential oncological markers related to the immature state of tumoral cells (nestin and Notch-1), their tumorigenicity [caveolae and epidermal growth factor-receptor (EGF-R)], or the MDR phenotype [P-glycoprotein (P-gp)]. The expression of P-gp, EGF-R, and caveolin-1 by these tumoral ependymocytes could be useful in studies on new drugs. This coculture model might represent a new powerful tool to study new therapeutic delivery strategies in tumoral cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239616

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy.

Authors:  Su Guan; Ruijun Shen; Tiffany Lafortune; Ningyi Tiao; Peter Houghton; W K Alfred Yung; Dimpy Koul
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

2.  Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.

Authors:  Vladimir Amani; Andrew M Donson; Seth C Lummus; Eric W Prince; Andrea M Griesinger; Davis A Witt; Todd C Hankinson; Michael H Handler; Kathleen Dorris; Rajeev Vibhakar; Nicholas K Foreman; Lindsey M Hoffman
Journal:  J Neuropathol Exp Neurol       Date:  2017-07-01       Impact factor: 3.685

3.  A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.

Authors:  Litian Yu; Patricia A Baxter; Horatiu Voicu; Sivashankarappa Gurusiddappa; Yijue Zhao; Adekunle Adesina; Tsz-Kwong Man; Qin Shu; Yu-Jing Zhang; Xiu-Mei Zhao; Jack M Su; Lazlo Perlaky; Robert Dauser; Murali Chintagumpala; Ching C Lau; Susan M Blaney; Pulivarthi H Rao; Hon-Chiu Eastwood Leung; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

4.  Nestin expression in the cell lines derived from glioblastoma multiforme.

Authors:  Renata Veselska; Petr Kuglik; Pavel Cejpek; Hana Svachova; Jakub Neradil; Tomas Loja; Jirina Relichova
Journal:  BMC Cancer       Date:  2006-02-02       Impact factor: 4.430

5.  Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines.

Authors:  Renata Veselska; Marketa Hermanova; Tomas Loja; Petr Chlapek; Iva Zambo; Karel Vesely; Karel Zitterbart; Jaroslav Sterba
Journal:  BMC Cancer       Date:  2008-10-16       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.